hI-con1

N/A

Report date: 2024/04/18 14:33:17

Base Information

Drug NamehI-con1
Drug Alias NameICON-1hI-con1
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionAngiogenesis inhibitorsNatural killer cells stimulantsTissue factor inhibitors
TargetsTissue factor
Therapy Area/IndicationsUveal melanomaChoroidal NeovascularizationWet age-related macular degeneration +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIconic Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsUveal melanomaChoroidal NeovascularizationWet age-related macular degeneration +[5] 

Other Information

ATC CodeN/A
Related LinksN/A